| Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study HJ Lamberink, WM Otte, I Blümcke, KPJ Braun, M Aichholzer, I Amorim, ... The Lancet Neurology 19 (9), 748-757, 2020 | 375 | 2020 |
| Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and … HJ Lamberink, WM Otte, AT Geerts, M Pavlovic, J Ramos-Lizana, ... The Lancet Neurology 16 (7), 523-531, 2017 | 332 | 2017 |
| European trends in epilepsy surgery MO Baud, T Perneger, A Rácz, MC Pensel, C Elger, B Rydenhag, ... Neurology 91 (2), e96-e106, 2018 | 184 | 2018 |
| The methodological quality of 176,620 randomized controlled trials published between 1966 and 2018 reveals a positive trend but also an urgent need for improvement CH Vinkers, HJ Lamberink, JK Tijdink, P Heus, L Bouter, P Glasziou, ... PLoS biology 19 (4), e3001162, 2021 | 114 | 2021 |
| Antiepileptic drug withdrawal in medically and surgically treated patients: a meta‐analysis of seizure recurrence and systematic review of its predictors HJ Lamberink, WM Otte, K Geleijns, KPJ Braun Epileptic Disorders 17 (3), 211-228, 2015 | 106 | 2015 |
| Changing profiles of pediatric epilepsy surgery candidates over time: a nationwide single‐center experience from 1990 to 2011 HJ Lamberink, K Boshuisen, PC van Rijen, PH Gosselaar, KPJ Braun, ... Epilepsia 56 (5), 717-725, 2015 | 86* | 2015 |
| Statistical power of clinical trials increased while effect size remained stable: an empirical analysis of 136,212 clinical trials between 1975 and 2014 HJ Lamberink, WM Otte, MRT Sinke, D Lakens, PP Glasziou, JK Tijdink, ... Journal of Clinical Epidemiology 102, 123-128, 2018 | 68 | 2018 |
| study group; European Reference Network EpiCARE. Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective … HJ Lamberink, WM Otte, I Blümcke, KPJ Braun Lancet Neurol 19 (9), 748-757, 2020 | 51 | 2020 |
| Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: a systematic review and individual … R Stevelink, D Al-Toma, FE Jansen, HJ Lamberink, AA Asadi-Pooya, ... EClinicalMedicine 53, 2022 | 39 | 2022 |
| Individualized prediction of seizure relapse and outcomes following antiepileptic drug withdrawal after pediatric epilepsy surgery HJ Lamberink, K Boshuisen, WM Otte, K Geleijns, KPJ Braun, ... Epilepsia 59 (3), e28-e33, 2018 | 37 | 2018 |
| Cognitive consequences of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery, the TimeToStop (TTS) trial: study protocol for a randomized … K Boshuisen, HJ Lamberink, MMJ van Schooneveld, JH Cross, ... Trials 16 (1), 482, 2015 | 30 | 2015 |
| A prediction model to determine childhood epilepsy after 1 or more paroxysmal events E Van Diessen, HJ Lamberink, WM Otte, N Doornebal, OF Brouwer, ... Pediatrics 142 (6), e20180931, 2018 | 25 | 2018 |
| Predictive models for starting antiseizure medication withdrawal following epilepsy surgery in adults C Ferreira-Atuesta, J de Tisi, AW McEvoy, A Miserocchi, J Khoury, R Yardi, ... Brain 146 (6), 2389-2398, 2023 | 24 | 2023 |
| Why the TimeToStop trial failed to recruit: a survey on antiepileptic drug withdrawal after paediatric epilepsy surgery HJ Lamberink, K Geleijns, WM Otte, A Arzimanoglou, J Helen Cross, ... Epileptic Disorders 20 (5), 374-385, 2018 | 21 | 2018 |
| Indicators of questionable research practices were identified in 163,129 randomized controlled trials JA Damen, P Heus, HJ Lamberink, JK Tijdink, L Bouter, P Glasziou, ... Journal of clinical epidemiology 154, 23-32, 2023 | 19 | 2023 |
| Deprescribing in epilepsy: do no harm SW Terman, HJ Lamberink, KPJ Braun JAMA neurology 77 (6), 673-674, 2020 | 17 | 2020 |
| Clinical trial registration patterns and changes in primary outcomes of randomized clinical trials from 2002 to 2017 HJ Lamberink, CH Vinkers, M Lancee, JAA Damen, LM Bouter, WM Otte, ... Jama internal medicine 182 (7), 779-782, 2022 | 13 | 2022 |
| Adequate statistical power in clinical trials is associated with the combination of a male first author and a female last author WM Otte, JK Tijdink, PL Weerheim, HJ Lamberink, CH Vinkers Elife 7, e34412, 2018 | 9 | 2018 |
| European Epilepsy Brain Bank writing g, study g, Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective … HJ Lamberink, WM Otte, I Blumcke, KPJ Braun Lancet Neurol 19 (9), 748-57, 2020 | 6 | 2020 |
| Cumulative effects of antiseizure medication on intelligence in children with focal epilepsy CH Stevering, HJ Lamberink, J Woodfield, M van Schooneveld, WM Otte, ... Epileptic Disorders, 877-888, 2022 | 4 | 2022 |
